The University of Cambridge said scientists have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients. The test gives doctors the information they need to start treatment within hours rather than days. It uses multiple PCR which detects the DNA of the bacteria.